A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.

Meet the Innovator of the Year for Men's Health honoree for Atlanta Business Chronicle's Health Care Champion Awards.

Ciara Foskin’s diagnosis came out of the blue. She is part of a small cohort of women under 50 who develop triple-negative ...

TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

Updated Phase 1 data for ELVN-001 expected mid-2025 as positive enrollment momentum continues Expected monotherapy and combination data from the ELVN-002 Phase 1 trials ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

Genetic testing, via germline and somatic testing, is crucial in breast cancer to understand inherited risks and tumor ...

Intensive chemo is used before treatment with gene-editing medicines ... Orum's in-house meanwhile efforts are now focused on ORM-5029, a HER2-targeting DAC that is in early-stage testing as ...

Tucatinib inhibits the tyrosine kinase enzyme of the HER-2 gene. Mutations of tyrosine kinase in the HER-2 gene lead to cascade effects of increased cell signaling and proliferation, resulting in ...

Authorities say Gene Hackman spent his final years retired from acting, living with heart disease and Alzheimer’s ...

Betsy Arakawa, the wife of the late Gene Hackman, died of hantavirus pulmonary syndrome, New Mexico officials said Friday.

Gene Hackman and Betsy Arakawa were found dead in their home last week in a gated community in Santa Fe, New Mexico.